Armistice Capital, LLC 13D and 13G filings for Citius Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 6:44 pm Sale |
2021-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR |
Armistice Capital, LLC | 97,000 1.600% |
-149,734 (-60.69%) |
Filing |
| 2021-02-16 3:00 pm Purchase |
2020-12-31 | 13G | Citius Pharmaceuticals, Inc. CTXR |
Armistice Capital, LLC | 246,734 9.990% |
118,297 (+92.11%) |
Filing |